148 related articles for article (PubMed ID: 37413854)
1. Investigation of the safety of live attenuated varicella-zoster virus vaccination in patients with relapse-remitting multiple sclerosis treated with natalizumab: A case series and review of the literature.
Paybast S; Sahraian MA; Nahayati MA; Habibi MA; Shahmohammadi S; Navardi S
Mult Scler Relat Disord; 2023 Sep; 77():104793. PubMed ID: 37413854
[TBL] [Abstract][Full Text] [Related]
2. Safety of anti-varicella zoster virus vaccination in patients with multiple sclerosis treated with natalizumab: A case series.
Lapucci C; Boccia VD; Sirito T; Cellerino M; Mikulska M; Sticchi L; Inglese M
Mult Scler; 2023 Oct; 29(11-12):1514-1517. PubMed ID: 37786976
[TBL] [Abstract][Full Text] [Related]
3. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K
Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755
[TBL] [Abstract][Full Text] [Related]
4. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
[TBL] [Abstract][Full Text] [Related]
5. Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus.
Heusel EH; Grose C
Viruses; 2020 Sep; 12(10):. PubMed ID: 32992805
[TBL] [Abstract][Full Text] [Related]
6. A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.
Gershon AA; Levin MJ; Weinberg A; Song LY; LaRussa PS; Steinberg SP; Bartlett P;
Pediatr Infect Dis J; 2009 Jul; 28(7):653-5. PubMed ID: 19561431
[TBL] [Abstract][Full Text] [Related]
7. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of varicella-zoster virus vaccine by different routes of administration: Comparable vaccination efficacy of one-fifth dose intradermal vaccination to conventional subcutaneous vaccination.
Nakamura-Nishimura Y; Shinkuma S; Miyagawa F; Haredy A; Gomi Y; Yamanishi K; Asada H
J Dermatol Sci; 2022 May; 106(2):86-92. PubMed ID: 35437206
[TBL] [Abstract][Full Text] [Related]
10. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
11. Varicella vaccine meningoencephalitis in a child receiving autologous bone marrow transplantation.
Coralie R; Ziad C; Christian R; Pierre T; Chantal B; Bruce T; Philippe O
Pediatr Transplant; 2023 Sep; 27(6):e14562. PubMed ID: 37395442
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults.
Weinberg A; Levin MJ; Macgregor RR
Hum Vaccin; 2010 Apr; 6(4):318-21. PubMed ID: 20372089
[TBL] [Abstract][Full Text] [Related]
13. Vaccine-Strain Varicella Virus Transmitted to a Term Infant Following Maternal Postpartum Vaccination.
Saringkarisate K; Len KA; Melish ME; Prothero BK; Ching N
J Pediatric Infect Dis Soc; 2022 Oct; 11(10):452-453. PubMed ID: 35751631
[TBL] [Abstract][Full Text] [Related]
14. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.
Uebe B; Sauerbrei A; Burdach S; Horneff G
Eur J Pediatr; 2002 Aug; 161(8):442-4. PubMed ID: 12172829
[TBL] [Abstract][Full Text] [Related]
15. Varicella-zoster virus vasculopathy in a patient with multiple sclerosis receiving natalizumab.
Elmståhl A; Buchwald F; Ilinca A
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38081745
[TBL] [Abstract][Full Text] [Related]
16. Immunization of healthy adults with live attenuated varicella vaccine.
Gershon AA; Steinberg SP; LaRussa P; Ferrara A; Hammerschlag M; Gelb L
J Infect Dis; 1988 Jul; 158(1):132-7. PubMed ID: 2839577
[TBL] [Abstract][Full Text] [Related]
17. Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.
Speth F; Hinze CH; Andel S; Mertens T; Haas JP
Pediatr Rheumatol Online J; 2018 Mar; 16(1):15. PubMed ID: 29499726
[TBL] [Abstract][Full Text] [Related]
18. A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older.
Berger R; Trannoy E; Holländer G; Bailleux F; Rudin C; Creusvaux H
J Infect Dis; 1998 Nov; 178 Suppl 1():S99-103. PubMed ID: 9852985
[TBL] [Abstract][Full Text] [Related]
19. Disseminated Varicella-Zoster Virus After Vaccination in an Immunocompetent Patient.
Scotch AH; Hoss E; Orenstein R; Budavari AI
J Am Osteopath Assoc; 2016 Jun; 116(6):402-5. PubMed ID: 27214778
[TBL] [Abstract][Full Text] [Related]
20. Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab.
Carvajal R; Zabalza A; Carbonell-Mirabent P; Martínez-Gómez X; Esperalba J; Pappolla A; Rando A; Cobo-Calvo A; Tur C; Rodriguez M; Río J; Comabella M; Castilló J; Rodrigo-Pendás JÁ; Braga N; Mongay-Ochoa N; Guío-Sánchez C; Vidal-Jordana Á; Arrambide G; Rodríguez-Acevedo B; Midaglia L; Borras-Bermejo B; Galán I; Sastre-Garriga J; Montalban X; Otero-Romero S; Tintoré M
JAMA Netw Open; 2024 Apr; 7(4):e246345. PubMed ID: 38607624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
